We are proud to announce creation of the new FARIL International initiative on President’s Day, February 20th, 2023.
We firmly believe that patients benefit when a diverse team of clinicians and researchers work to bridge geographic distances. Accordingly, for years the Foot & Ankle Research and Innovation Laboratory (FARIL) at the Massachusetts General Hospital in Boston has been global in its mindset, attracting the best and brightest minds from around the world to spend time in our facility translating foot and ankle research from the benchtop to the bedside. FARIL International is, therefore, a natural expansion of FARIL, representing a groundbreaking initiative that empowers a network of orthopaedic scientists, clinicians, and researchers from around the world to advance foot and ankle research while physically located in their home countries. FARIL International has been created to provide the physical and human resources, logistical support, and appropriate platform to enable a team-based approach to exchange knowledge and share skillsets across the global network of experts needed to drive meaningful progress in this field. As the first of its kind worldwide, FARIL International focuses its mission on being the world leader for the advancement of innovative solutions to currently unsolved orthopaedic challenges for the foot and ankle populations we serve. It is comprised of an extended network of current and past FARIL clinicians, scientists, researchers, and innovators who currently serve as ambassadors from different countries spanning four continents and who are devoted to working together in concert with FARIL’s Boston-based multidisciplinary research team. This new platform promises to facilitate previously challenging large scale database studies, multi-center prospective and retrospective clinical trials, biomechanical research, and cadaveric experiments that incubate novel device development and evolve new diagnostic and treatment techniques to long standing therapeutic patient care dilemmas. Imagine clinical studies whose patient participants are genuinely representative of our global diversity, or AI solutions that are built explicitly to avoid ethnocentric bias by incorporating global datasets. FARIL International can catalyze such realities alongside nationally and internationally based collaborative workshops, seminars, lectures, and educational courses with the aim of educating, guiding, and encouraging orthopaedic research, innovation, and contribution on behalf of both our patients and their providers. This initiative envisions a uniquely empowered ability to drive breakthroughs in foot and ankle orthopaedic care that empowers clinicians and improves the quality of life for our patients worldwide.
– Christopher W. DiGiovanni